OCEANSIDE, CA--(Marketwired - January 07, 2014) - AsthmaSense® Prime, iSonea Ltd.'s next-generation smartphone application that serves as one's personal asthma monitor, will be previewed at the 2014 International CES® Jan. 7-10, 2014, in Las Vegas.
AsthmaSense Prime is equipped with unprecedented features to help inform users about changing asthma risks based on symptoms, triggers, medication usage and environmental factors -- pollen, weather and air quality -- that can amplify symptoms or provoke an attack. AsthmaSense Prime makes it easy to record objective data related to one's asthma management to share with physicians or family members.
In addition, AsthmaSense Prime has the ability to automatically incorporate wheeze measurement data when used with AirSonea™, the world's first smartphone-enabled device for monitoring wheeze. Wheeze is a cardinal sign of asthma associated with airway obstruction.
Currently available in Australia and granted a CE mark for the European market, the AirSonea device is not yet available in the United States.
AsthmaSense Prime will be demonstrated at the iSonea booth number 26521 located in South Hall 2 of the Las Vegas Convention Center.
"The iSonea team is thrilled to showcase its new asthma solution, AsthmaSense Prime, at the world's premier consumer technology show," said Jerry Korten, chief executive officer of iSonea. "CES is an ideal venue for a leader in the mHealth space like iSonea to reveal future products and applications to the international consumer technology market."
In addition, Korten will speak at the Living in Digital Times stage on Friday, Jan. 10 at 9 a.m. PT located in the Las Vegas Convention Center in South Hall 2 at booth 25515. Addressing technology enthusiasts and media, Korten's presentation will highlight iSonea's history as a mHealth leader as well as its up-and-coming products like AirSonea and AsthmaSense Prime.
With more than 29 years of experience in the medical device industry, Korten was previously CEO for Versamed Inc. which was acquired by GE Healthcare. He also is active in the medical device startup scene as "entrepreneur in residence" for the Partnership Fund for New York City and served as "executive in residence" for Columbia University in the past.
For more information, please visit the iSonea newsroom.
About iSonea Ltd.:
iSonea Ltd. (ASX: ISN) is an emerging medical technology company developing innovative, non-invasive devices and mobile health apps to improve the management of chronic, costly respiratory disorders such as asthma and COPD. By leveraging iSonea's proprietary Acoustic Respiratory Monitoring™ (ARM) technology with its AsthmaSense®mobile applications, iSonea is turning smart phones into medical devices -- enabling anyone, anywhere, at any time to monitor breathing distress symptoms, in order to take action. iSonea's ARM devices have been cleared for use by the United States Food and Drug Administration, the Australian TGA and the European Union CE.
For more information, please visit www.iSoneaMed.com and www.AsthmaSense.com.
Forward Looking Statements
About Living in Digital Times:
Living in Digital Times produces conferences and exhibits throughout the year that bring together the most knowledgeable leaders and the latest innovations that intersect technology and lifestyle. Among their many goals is to help companies understand what it means to be a consumer in today's digital world and stay a step ahead in identifying key trends in their given marketplace. Living in Digital Times produces the following summits, exhibitions and events annually at International CES: Digital Health Summit, Silvers Summit, FitnessTech Summit, TransformingEDU, Kids@Play Summit, MommyTech Summit, Mobile Apps Showdown, Last Gadget Standing, FashionWare Show and the KAPi Awards. For more information, visit www.LivinginDigitalTimes.com.
The following files are available for download: